Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
Revenue
Fulgent Genetics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Revenue
$289.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
See Also
What is Fulgent Genetics Inc's Revenue?
Revenue
289.2m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Revenue amounts to 289.2m USD.
What is Fulgent Genetics Inc's Revenue growth rate?
Revenue CAGR 5Y
68%
Over the last year, the Revenue growth was -53%. The average annual Revenue growth rates for Fulgent Genetics Inc have been -12% over the past three years , 68% over the past five years .